home / stock / mreo / mreo news


MREO News and Press, Mereo BioPharma Group From 01/19/26

Stock Information

Company Name: Mereo BioPharma Group
Stock Symbol: MREO
Market: NASDAQ
Website: mereobiopharma.com

Menu

MREO MREO Quote MREO Short MREO News MREO Articles MREO Message Board
Get MREO Alerts

News, Short Squeeze, Breakout and More Instantly...

MREO - MREO Investor Notice: Levi & Korsinsky Investigates Mereo BioPharma Group plc for Securities Law Violations

New York, New York--(Newsfile Corp. - January 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Mereo BioPharma Group plc (NASDAQ: MREO) ("Mereo BioPharma Group plc") concerning potential violations of the federal securities laws. On December 29...

MREO - Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

2026-01-14 18:55:57 ET Mereo BioPharma Group plc (MREO) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Mereo BioPharma Group plc (MREO) Presents at 44th Annual J.P. Morgan Healthca...

MREO - US Companies Moving the Markets, Evening edition
Mon, Jan 12, 2026 as of 4:00 pm ET

A look at the top 10 most actives in the United States Envirotech Vehicles Inc. (EVTV) rose 295.2% to $1.83 on volume of 610,320,780 shares Oriental Culture Holding LTD (OCG) fell 15.0% to $0.017 on volume of 389,655,949 shares Mingteng International Corporation Inc. (MTEN) fell 43.7% to $0...

MREO - Morning Market Pulse: From Clinical Crossroads to Capital Discipline, a Market Sorting Signal Emerges

2026-01-12 09:38:49 ET Morning Market Pulse: From Clinical Crossroads to Capital Discipline, a Market Sorting Signal Emerges This morning’s news flow underscores a familiar but critical market dynamic: the separation between promise, proof, and prudence . Here’s ho...

MREO - Mereo BioPharma Provides Corporate Update

Additional data analyses from Orbit and Cosmic Phase 3 studies of setrusumab (UX143) in osteogenesis imperfecta ongoing to determine potential path forward for the program  Cash balance of approximately $41 million as of December 31, 2025; runway guidance updated to mid-2027 LONDON, J...

MREO - US Companies Moving the Markets, Morning edition
Wed, Jan 07, 2026 as of 10.00 am ET

A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 9.8% to $2.38 on volume of 499,512,142 shares Oriental Culture Holding LTD (OCG) fell 41.3% to $0.0222 on volume of 476,557,433 shares Envirotech Vehicles Inc. (EVTV) rose 49.0% to...

MREO - Ultragenyx recovers some losses as Jefferies sees potential 2026 rebound

2025-12-30 12:46:38 ET More on Ultragenyx Pharmaceutical Ultragenyx: Why I'm Selling The Osteogenesis Imperfecta Dip Ultragenyx Pharmaceutical Inc. (RARE) Presents at Evercore 8th Annual Healthcare Conference Transcript Ultragenyx Pharmaceutical Inc. (RARE) Presents ...

MREO - US Companies Moving the Markets, Morning edition
Tue, Dec 30, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Republic Power Group Ltd (RPGL) rose 159.6% to $0.6834 on volume of 526,371,087 shares Mereo BioPharma Group plc (MREO) fell 87.6% to $0.2854 on volume of 241,447,142 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 1.0% t...

MREO - MREO Price Target Alert: $0.50. Issued by Jefferies

2025-12-30 06:05:40 ET Maury Raycroft from Jefferies issued a price target of $0.50 for MREO on 2025-12-30 09:54:00. The adjusted price target was set to $0.50. At the time of the announcement, MREO was trading at $0.2854. The overall price target consensus is at $2.33 w...

MREO - Hold Recommendation Issued On MREO By Jefferies

2025-12-29 20:15:03 ET Jefferies analyst issues HOLD recommendation for MREO on December 30, 2025 01:47AM ET. MREO was trading at $0.2854 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 6 - Buy recommenda...

Previous 10 Next 10